title: New recommendations in prostate cancer screening and treatment.
abstract: Prostate cancer is the most commonly diagnosed nonskin cancer in men, with 233,000 new cases estimated for 2014. Nearly 30,000 deaths are predicted for 2014, second only to lung and bronchial cancer deaths. Early diagnosis is key to improving patient survival rates. Screening efforts have dramatically increased the detection rate, and now, 90% of new diagnoses are caught at the early stage of disease. However, new data are driving controversial changes to screening and treatment recommendations.
authors.affiliation: Lisa K. Adams practices hematology/oncology at Feist-Weiller Cancer Center in Shreveport, La., and is a recent graduate of the PA program at Louisiana State University's Health Sciences Center in Shreveport, La. Lindsay S. Ferrington is an instructor in the Louisiana State University PA program. The authors have disclosed no potential conflicts of interest, financial or otherwise.
authors.forename: Lisa K
authors.initials: LK
authors.lastname: Adams
authors.forename: Lindsay S
authors.initials: LS
authors.lastname: Ferrington
mesh_terms: D000368:Aged; D055088:Early Detection of Cancer; D006801:Humans; D008297:Male; D008875:Middle Aged; D010358:Patient Participation; D017410:Practice Guidelines as Topic; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*